CLINICAL_TRIALS
trial_result
· 2015-12-10
Clinical Trial Update: Memantine for Recurrent Glioblastoma [Phase 2]
Summary
A Phase 2 trial of memantine for recurrent glioblastoma was terminated; results were posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Rochester | Conditions: Glioblastoma | Phase 2 | Status: TERMINATED | Results posted: 2015-12-10